Full List Of Stories
Citi cautious on Indivior until evidence of acceleration to product release
Pharmaceuticals business Indivior had its target price lowered from 350p to 240p by investment bank Citi due to concern that there is not “sufficient evidence” that the launch of Sublocade is accelerating.
FTSE 250 movers: Convatec plummets, upgrades drive AA and Avast
London's mid cap index fell 170 points to 18,803. 45 on Monday, led by Convatec and Superdry.
Asia report: Markets drop as Saudi tension and trade war worries spook investors
Returning to face a new week after the last one saw the region’s indices face deep declines, Asian markets dropped again on Monday as they failed to follow Wall Street’s Friday recovery.
System1's loss narrowing more slowly than expected
Marketing services group System1 said on Monday that its gross profit was “stabilising” after the company invested heavily in subscription service offering Ad Ratings.
Eden Research pens distribution agreement for grape fungicide
Eden Research on Monday signed an exclusive distribution agreement for Sipcam to sell grape fungicide product Novellus in Australia and New Zealand.
Tekcapital's subsidiary Lucyd 'excited' by Brazilian partnership
Tekcapital’s wholly owned portfolio company Lucyd on Monday made its first sale to a Brazilian optical retailer as part of a newly-formed reseller partnership between the two companies.
New contract wins of £15m spark revenue growth at Ixico
Ixico has achieved a 32% increase in annual revenues after expanding the range of medical imaging services that it provides, the company said on Monday.